Format

Send to

Choose Destination
P T. 2017 Apr;42(4):237-241.

Flibanserin (Addyi): The First FDA-Approved Treatment for Female Sexual Interest/Arousal Disorder in Premenopausal Women.

Abstract

Flibanserin (Addyi) for female sexual interest/arousal disorder in premenopausal women.

PMID:
28381915
PMCID:
PMC5358680

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center